Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.8.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.4.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDRNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.43.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.7.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KV.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JD.1.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.43NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JC.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDPNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.3.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.15.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JS.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.2.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HG.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GE.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCQNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JC.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.41.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.70NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JG.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JM.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.22.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCFNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used